P J Goodnick

Summary

Publications

  1. ncbi Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathy
    P J Goodnick
    Department of Psychiatry, University of Miami School of Medicine, Florida 33136, USA
    Ann Clin Psychiatry 13:31-41. 2001
  2. ncbi Use of olanzapine in non-psychotic psychiatric disorders
    P J Goodnick
    Department of Psychiatry and Behavioral Sciences, University of Miami School of Medicine, D79, 1400 NW 10 Avenue, Miami, Florida 33136, USA
    Expert Opin Pharmacother 2:667-80. 2001
  3. ncbi Ziprasidone: profile on safety
    P J Goodnick
    Department of Psychiatry and Behavioral Sciences, University of Miami School of Medicine, 1400 NW 10 Avenue, Ste 304A, Mail Code D79, Miami, Florida 33136, USA
    Expert Opin Pharmacother 2:1655-62. 2001
  4. ncbi Mirtazapine in major depression with comorbid generalized anxiety disorder
    P J Goodnick
    Department of Psychiatry and Behavioral Sciences, University of Miami School of Medicine, Fla 33136, USA
    J Clin Psychiatry 60:446-8. 1999
  5. ncbi The use of nimodipine in the treatment of mood disorders
    P J Goodnick
    Department of Psychiatry and Behavioral Sciences, University of Miami School of Medicine, FL 33136, USA
    Bipolar Disord 2:165-73. 2000
  6. ncbi Antipsychotic medication: effects on regulation of glucose and lipids
    M M Kato
    Department of Psychiatry and Behavioral Sciences, University of Miami School of Medicine, 1400 NW 10 Avenue, Ste 304A, Miami, FL 33136, USA
    Expert Opin Pharmacother 2:1571-82. 2001

Collaborators

  • M M Kato

Detail Information

Publications6

  1. ncbi Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathy
    P J Goodnick
    Department of Psychiatry, University of Miami School of Medicine, Florida 33136, USA
    Ann Clin Psychiatry 13:31-41. 2001
    ..In diabetic neuropathy without depression, the best choices among non-TCAs may include sertraline, citalopram, and perhaps, venlafaxine, since the TCAs appear to increase cravings and increase FBG levels...
  2. ncbi Use of olanzapine in non-psychotic psychiatric disorders
    P J Goodnick
    Department of Psychiatry and Behavioral Sciences, University of Miami School of Medicine, D79, 1400 NW 10 Avenue, Miami, Florida 33136, USA
    Expert Opin Pharmacother 2:667-80. 2001
    ..In each of these latter diagnoses, double-blind studies are either underway or are planned to establish efficacy...
  3. ncbi Ziprasidone: profile on safety
    P J Goodnick
    Department of Psychiatry and Behavioral Sciences, University of Miami School of Medicine, 1400 NW 10 Avenue, Ste 304A, Mail Code D79, Miami, Florida 33136, USA
    Expert Opin Pharmacother 2:1655-62. 2001
    ....
  4. ncbi Mirtazapine in major depression with comorbid generalized anxiety disorder
    P J Goodnick
    Department of Psychiatry and Behavioral Sciences, University of Miami School of Medicine, Fla 33136, USA
    J Clin Psychiatry 60:446-8. 1999
    ..Because of mirtazapine's early anxiolytic effects, the present study was undertaken as a preliminary investigation in patients with a diagnosis of major depression with comorbid GAD...
  5. ncbi The use of nimodipine in the treatment of mood disorders
    P J Goodnick
    Department of Psychiatry and Behavioral Sciences, University of Miami School of Medicine, FL 33136, USA
    Bipolar Disord 2:165-73. 2000
    ..g., ultra-rapid-cycling bipolars and brief recurrent depressions...
  6. ncbi Antipsychotic medication: effects on regulation of glucose and lipids
    M M Kato
    Department of Psychiatry and Behavioral Sciences, University of Miami School of Medicine, 1400 NW 10 Avenue, Ste 304A, Miami, FL 33136, USA
    Expert Opin Pharmacother 2:1571-82. 2001
    ..Ziprasidone appears to be the antipsychotic with the most beneficial combination of effects: no weight gain, no change in glucose utilisation and reductions in cholesterol and serum triglycerides (TGs)...